Shahab is currently appointed as Assistant Professor at Division of Pharmacoepidemiology and Clinical Pharmacology of UIPS at Utrecht University. He did his postdoc at Utrecht University between 2021-2023, defended his PhD in ‘Pharmacoepidemiology’ at Maastricht University in 2021, finished a master course in 'Vitality and Ageing' at Leiden University in 2016, and graduated in 'General Medicine' from Tehran University of Medical Sciences in 2011.

Shahab has a strong interest in studying drugs utilisation and outcomes using real-world data from electronic healthcare databases, with a particular focus on signal detection methodologies. They have recently finished projects, such as: "Impact of EU risk minimisation measures on utilisation of valproates & oral retinoids in Europe", and "Risk awareness and adherence with EU regulatory communication on thrombosis with thrombocytopenia syndrome and SARS-CoV-2 adenovirus vaccines", and he is actively working on: "Sapere Aude project - Hypothesis-free screening for adverse events: A new approach in drug safety research", “ISPE manuscript on quality control processes of large pharmacoepidemiologic studies using heterogenous data sources”, and "A multinational big data Covid-19 Epidemiological Study on post-infection Outcomes (ACESO)".

Besides research, he teaches several courses in pharmacoepidemiology, and supervises PhD, master and bachelor students at Utrecht University. He is also course coordinator, instructor, and course developer at the Eu2P, the first European training programme in pharmacovigilance and pharmacoepidemiology.

Furthermore, he acts as chair-elect of Databases Special Interest Group (DB SIG) at the International Society for Pharmacoepidemiology.